The Journal of Laryngology & Otology· 2026Q2
Efficacy of sinus drug-eluting stents for chronic rhinosinusitis with nasal polyps: a multidimensional study
- 0citations
- Q2SCImago
- 2026year
Short summary
Implanting drug-eluting stents in the middle meatus alongside functional endoscopic sinus surgery (FESS) significantly improved subjective symptoms and reduced inflammation markers (MMP-9) by 12 months compared to FESS alone in chronic rhinosinusitis patients (n=60).
AI-generated from the title and abstract; the full text is not read.
Key points
- Drug-eluting stents combined with FESS led to greater MMP-9 reduction at 12 months compared to FESS alone.
- The stent group also experienced more significant decreases in subjective symptom scores at the 12-month follow-up.
- Both treatment approaches improved symptoms and mucosal morphology, but the stent offered an added benefit.
- Study included 60 chronic rhinosinusitis with nasal polyps patients with assessments at pre-op, 3 months, and 12 months.
AI-generated from the title and abstract; the full text is not read.
Abstract
Abstract Objective To compare the efficacy of intra-operative middle meatus drug-eluting stent implantation versus standalone functional endoscopic sinus surgery (FESS) for chronic rhinosinusitis in subjective symptoms, mucosal morphology and inflammatory factors. Methods Sixty chronic rhinosinusitis with nasal polyps patients (Changsha Central Hospital, January 2023 to June 2024) were assigned to two groups based on voluntary treatment preference: an experimental group with intra-operative stent implantation and a control group with standalone FESS. The Sino-Nasal Outcome Test 22, Lund–Kennedy scores and nasal secretion Matrix Metalloproteinase-9 (MMP-9) were assessed pre-operatively, and 3 and 12 months post-operatively. Data were analysed by SPSS 27.0 ( p < 0.05 for significance). Results All indicators decreased post-operatively in both groups ( p < 0.05). MMP-9 reduction was similar at 3 months ( p > 0.05); at 12 months, the experimental group had greater MMP-9 reduction and more significant decreases in related symptom scores ( p < 0.05). Conclusion Intra-operative middle meatus drug-eluting stent implantation may provide additional benefits compared with standalone FESS in improving subjective symptoms, accelerating nasal mucosal repair and inhibiting inflammation within 12 months of follow up.
The authors' abstract, as published at the source. The Journal of Laryngology & Otology, 2026 · DOI ↗
Continue with a free account
Ask the paper: 3 free questions a day about this paper; save it, get its citation, new summaries every day for your field. Takeaways are Premium.
Continue free on the webSign in with Google or Apple; no card needed. You come back to this paper.
On your phone:
Field: Otorhinolaryngology
OtorhinolaryngologyMedicine